Nicotinamide ribose is also known as niagen. It is an alternative form of vitamin B3; hence it is also known as niacin. It is further converted into nicotinamide adenine dinucleotide (NAD+), a coenzyme or helper molecule. The NAD+ levels in the body are associated with health factors such as aging and chronic diseases such as diabetes, heart disease, Alzheimer's disease, and vision loss. The primary function of NAD+ is to act as a fuel for many vital biological processes.
MARKET DYNAMICS
The nicotinamide ribose market growth is estimated to grow due to the growing geriatric population, increasing product development, and rising demand for dietary supplements. The market is expected to have vital growth opportunities in the developing regions owing to rising demand for advanced healthcare and wellness products. Growing investment for research and developments in pharmaceutical industry.
MARKET SCOPE
The "Nicotinamide Ribose Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of nicotinamide ribose market with detailed market segmentation by type, application, and distribution channel. The nicotinamide ribose market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in nicotinamide ribose market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The nicotinamide ribose market is segmented on the basis of type, application, and distribution channel. Based on type, the market is classified as pharmaceutical grade, and food grade. Based on application, the market is segmented as energy metabolism, cellular repair, healthy aging, and others. On the basis of distribution channel, the market is segmented as hospitals and retail pharmacies, and online distribution.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the nicotinamide ribose market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The nicotinamide ribose market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting nicotinamide ribose market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the nicotinamide ribose market in these regions.
MARKET PLAYERS
The report covers key developments in the nicotinamide ribose market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from nicotinamide ribose market are anticipated to have lucrative growth opportunities in the future with the rising demand for nicotinamide ribose market in the global market. Below mentioned is the list of few companies engaged in the nicotinamide ribose market.
The report also includes the profiles of key players in nicotinamide ribose market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
-ChromaDex Corp.
-Elysium Health, Inc.
-Thorne
-BONTAC BIO-ENGINEERING (SHENZHEN) CO., LTD
-Solgar
-ProHealth, Inc
-Genex Formulas
-Cytoplan Ltd
-NOW Foods
-Zhejiang Dazhan Biotechnology Co., Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.